China Historical Financial Ratios

SXTC Stock

USD 0.43 0.05 10.42%

China SXT is presently reporting on over 92 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 15.26, Invested Capital of 0.0, Average Payables of 1.8 M or Stock Based Compensation To Revenue of 0.17 will help investors to properly organize and evaluate China SXT Pharmaceuticals financial condition quickly.

Quick Ratio Current Ratio

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in China SXT Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

About China Financial Ratios Analysis

China SXT PharmaceuticalsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate China SXT investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on China financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across China SXT history.

China SXT Financial Ratios Chart

At present, China SXT's Inventory Turnover is projected to increase slightly based on the last few years of reporting. The current year's Payables Turnover is expected to grow to 1.43, whereas Price To Sales Ratio is forecasted to decline to 0.71.

Price To Sales Ratio Ptb Ratio Days Sales Outstanding Book Value Per Share Free Cash Flow Yield Roic

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing China SXT Pharmaceuticals stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on China SXT sales, a figure that is much harder to manipulate than other China SXT Pharmaceuticals multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.

Free Cash Flow Yield

A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.

Roic

Return on Invested Capital, a profitability ratio that measures the return that an investment generates for those who have provided capital, such as debt holders and equity holders.

Most ratios from China SXT's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into China SXT Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in China SXT Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

	2021	2022	2023	2024 (projected)
Days Sales Outstanding	689.27	248.91	254.83	327.46
PTB Ratio	0.35	0.13	0.1	0.0982

Days Sales Outstanding Ptb Ratio

China SXT fundamentals Correlations

	Price To Sales Ratio	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Average Payables	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Average Inventory	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe
Price To Sales Ratio		1.0	-0.33	0.94	0.55	0.32	0.63	0.47	1.0	0.42	-0.75	0.72	-0.19	0.63	0.15	0.07	0.79	0.28	0.94	0.99	0.9	0.59	-0.99	0.03	0.69	0.81
Ptb Ratio	1.0		-0.36	0.93	0.53	0.37	0.65	0.47	1.0	0.4	-0.72	0.73	-0.18	0.62	0.14	0.07	0.79	0.29	0.93	1.0	0.91	0.6	-1.0	0.03	0.69	0.8
Days Sales Outstanding	-0.33	-0.36		-0.02	0.3	0.16	-0.44	-0.4	-0.36	-0.02	0.43	-0.15	-0.27	-0.72	0.31	-0.31	0.0	-0.17	-0.02	-0.39	-0.3	-0.13	0.44	0.32	-0.34	-0.62
Book Value Per Share	0.94	0.93	-0.02		0.71	0.49	0.45	0.47	0.93	0.5	-0.58	0.79	-0.16	0.33	0.13	0.07	0.77	0.39	1.0	0.91	0.82	0.63	-0.89	0.03	0.56	0.59
Free Cash Flow Yield	0.55	0.53	0.3	0.71		0.33	-0.1	0.29	0.53	0.35	-0.3	0.39	-0.01	0.01	0.08	-0.05	0.46	0.4	0.73	0.49	0.44	0.28	-0.48	0.16	0.12	0.2
Operating Cash Flow Per Share	0.32	0.37	0.16	0.49	0.33		0.17	0.27	0.37	0.2	0.37	0.6	0.1	-0.36	-0.06	0.0	0.37	0.42	0.47	0.38	0.33	0.37	-0.32	0.04	0.07	-0.14
Average Payables	0.63	0.65	-0.44	0.45	-0.1	0.17		0.19	0.65	-0.28	-0.49	0.5	-0.24	0.6	0.17	0.02	0.72	-0.12	0.45	0.67	0.83	0.03	-0.67	0.04	0.82	0.7
Capex To Depreciation	0.47	0.47	-0.4	0.47	0.29	0.27	0.19		0.47	0.34	-0.27	0.54	0.41	0.21	-0.38	0.4	0.0	0.92	0.47	0.47	0.36	0.41	-0.46	-0.41	0.36	0.39
Pb Ratio	1.0	1.0	-0.36	0.93	0.53	0.37	0.65	0.47		0.4	-0.72	0.73	-0.18	0.62	0.14	0.07	0.79	0.29	0.93	1.0	0.91	0.6	-1.0	0.03	0.69	0.8
Ev To Sales	0.42	0.4	-0.02	0.5	0.35	0.2	-0.28	0.34	0.4		-0.28	0.36	0.1	0.04	-0.16	0.24	0.06	0.43	0.49	0.38	0.0	0.91	-0.37	-0.27	-0.11	0.15
Free Cash Flow Per Share	-0.75	-0.72	0.43	-0.58	-0.3	0.37	-0.49	-0.27	-0.72	-0.28		-0.31	0.23	-0.84	-0.15	-0.1	-0.52	0.01	-0.6	-0.7	-0.65	-0.32	0.75	0.03	-0.63	-0.87
Roic	0.72	0.73	-0.15	0.79	0.39	0.6	0.5	0.54	0.73	0.36	-0.31		0.27	0.11	-0.29	0.54	0.58	0.47	0.77	0.71	0.67	0.5	-0.69	-0.44	0.34	0.5
Inventory Turnover	-0.19	-0.18	-0.27	-0.16	-0.01	0.1	-0.24	0.41	-0.18	0.1	0.23	0.27		-0.28	-0.98	0.77	-0.35	0.54	-0.18	-0.21	-0.25	-0.07	0.18	-0.84	-0.39	-0.14
Net Income Per Share	0.63	0.62	-0.72	0.33	0.01	-0.36	0.6	0.21	0.62	0.04	-0.84	0.11	-0.28		0.24	0.01	0.43	-0.12	0.35	0.64	0.6	0.22	-0.69	0.07	0.6	0.9
Days Of Inventory On Hand	0.15	0.14	0.31	0.13	0.08	-0.06	0.17	-0.38	0.14	-0.16	-0.15	-0.29	-0.98	0.24		-0.76	0.31	-0.49	0.15	0.17	0.22	0.03	-0.13	0.86	0.31	0.1
Payables Turnover	0.07	0.07	-0.31	0.07	-0.05	0.0	0.02	0.4	0.07	0.24	-0.1	0.54	0.77	0.01	-0.76		-0.07	0.37	0.06	0.06	-0.02	0.21	-0.07	-0.97	-0.29	0.28
Average Inventory	0.79	0.79	0.0	0.77	0.46	0.37	0.72	0.0	0.79	0.06	-0.52	0.58	-0.35	0.43	0.31	-0.07		-0.16	0.77	0.79	0.86	0.28	-0.78	0.2	0.59	0.6
Capex To Revenue	0.28	0.29	-0.17	0.39	0.4	0.42	-0.12	0.92	0.29	0.43	0.01	0.47	0.54	-0.12	-0.49	0.37	-0.16		0.38	0.28	0.13	0.41	-0.26	-0.41	0.08	0.06
Cash Per Share	0.94	0.93	-0.02	1.0	0.73	0.47	0.45	0.47	0.93	0.49	-0.6	0.77	-0.18	0.35	0.15	0.06	0.77	0.38		0.91	0.82	0.62	-0.89	0.05	0.56	0.61
Pocfratio	0.99	1.0	-0.39	0.91	0.49	0.38	0.67	0.47	1.0	0.38	-0.7	0.71	-0.21	0.64	0.17	0.06	0.79	0.28	0.91		0.91	0.6	-1.0	0.05	0.69	0.81
Interest Coverage	0.9	0.91	-0.3	0.82	0.44	0.33	0.83	0.36	0.91	0.0	-0.65	0.67	-0.25	0.6	0.22	-0.02	0.86	0.13	0.82	0.91		0.24	-0.91	0.14	0.82	0.77
Capex To Operating Cash Flow	0.59	0.6	-0.13	0.63	0.28	0.37	0.03	0.41	0.6	0.91	-0.32	0.5	-0.07	0.22	0.03	0.21	0.28	0.41	0.62	0.6	0.24		-0.57	-0.19	0.08	0.36
Pfcf Ratio	-0.99	-1.0	0.44	-0.89	-0.48	-0.32	-0.67	-0.46	-1.0	-0.37	0.75	-0.69	0.18	-0.69	-0.13	-0.07	-0.78	-0.26	-0.89	-1.0	-0.91	-0.57		-0.02	-0.71	-0.83
Days Payables Outstanding	0.03	0.03	0.32	0.03	0.16	0.04	0.04	-0.41	0.03	-0.27	0.03	-0.44	-0.84	0.07	0.86	-0.97	0.2	-0.41	0.05	0.05	0.14	-0.19	-0.02		0.3	-0.15
Income Quality	0.69	0.69	-0.34	0.56	0.12	0.07	0.82	0.36	0.69	-0.11	-0.63	0.34	-0.39	0.6	0.31	-0.29	0.59	0.08	0.56	0.69	0.82	0.08	-0.71	0.3		0.61
Roe	0.81	0.8	-0.62	0.59	0.2	-0.14	0.7	0.39	0.8	0.15	-0.87	0.5	-0.14	0.9	0.1	0.28	0.6	0.06	0.61	0.81	0.77	0.36	-0.83	-0.15	0.61

Click cells to compare fundamentals

China SXT Account Relationship Matchups

China SXT fundamentals Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Price To Sales Ratio	2.68	5.54	2.24	0.96	0.75	0.71
Ptb Ratio	1.47	1.66	0.35	0.13	0.1	0.0982
Days Sales Outstanding	752.83	593.38	689.27	248.91	254.83	327.46
Book Value Per Share	760.38	554.56	394.91	55.03	16.06	15.26
Free Cash Flow Yield	0.0381	(0.0532)	0.0353	(0.08)	(1.34)	(1.28)
Operating Cash Flow Per Share	75.56	(45.74)	6.45	(0.3)	(2.22)	(2.11)
Capex To Depreciation	1.23	0.27	0.2	0.28	0.0348	0.033
Pb Ratio	1.47	1.66	0.35	0.13	0.1	0.0982
Ev To Sales	2.57	2.76	(2.94)	(5.94)	(4.14)	(3.93)
Free Cash Flow Per Share	42.67	(48.98)	4.95	(0.57)	(2.23)	(2.34)
Inventory Turnover	2.38	2.75	2.25	1.33	2.91	2.54
Net Income Per Share	(832.08)	(95.48)	(137.92)	(22.23)	(3.57)	(3.75)
Days Of Inventory On Hand	132.54	161.91	274.98	125.47	215.03	136.18
Payables Turnover	1.27	1.33	0.91	1.12	1.07	1.43
Capex To Revenue	0.0788	0.0195	0.024	0.0358	0.003662	0.003479
Cash Per Share	589.37	463.24	373.26	65.06	13.92	13.22
Pocfratio	14.82	(20.11)	21.7	(23.44)	(0.75)	(0.71)
Interest Coverage	1.28	(1.36)	(23.78)	(11.76)	(4.62)	(4.39)
Capex To Operating Cash Flow	0.44	(0.0707)	0.23	(0.88)	(0.003663)	(0.00348)
Pfcf Ratio	26.25	(18.79)	28.29	(12.5)	(0.74)	(0.78)
Days Payables Outstanding	288.18	274.3	400.55	325.43	339.77	237.1
Income Quality	(0.0908)	0.48	(0.0468)	0.0136	0.62	0.53
Roe	(1.09)	(0.17)	(0.35)	(0.4)	(0.22)	(0.21)
Ev To Operating Cash Flow	14.22	(10.02)	(28.53)	145.11	4.14	3.93
Pe Ratio	(1.35)	(9.64)	(1.02)	(0.32)	(0.46)	(0.44)
Return On Tangible Assets	(0.48)	(0.0797)	(0.17)	(0.2)	(0.13)	(0.14)
Ev To Free Cash Flow	25.18	(9.36)	(37.2)	77.38	4.13	4.33
Earnings Yield	(0.74)	(0.1)	(0.99)	(3.14)	(2.15)	(2.26)
Intangibles To Total Assets	0.002306	0.001326	0.001155	9.43E-4	8.26E-4	7.85E-4
Net Debt To E B I T D A	0.56	7.18	2.67	2.61	4.01	4.21
Current Ratio	2.47	1.6	1.25	1.31	1.35	1.19
Tangible Book Value Per Share	756.33	552.97	393.98	54.92	16.04	15.24
Receivables Turnover	0.48	0.62	0.53	1.47	1.43	1.21
Graham Number	3.8K	1.1K	1.1K	165.9	35.93	34.13
Shareholders Equity Per Share	760.38	554.56	394.91	55.03	16.06	15.26
Debt To Equity	0.0273	0.72	0.00272	0.23	0.17	0.26
Capex Per Share	32.89	3.23	1.5	0.26	0.008143	0.007735

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

When determining whether China SXT Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of China SXT's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of China Sxt Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on China Sxt Pharmaceuticals Stock:

How To Invest In China

Details

Is China Stock a good investment?

Details

What is China SXT's Net Worth?

Details

Largest Personal Care Products Companies

View

Largest Drug Manufacturers - Specialty & Generic Companies

View

You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of China SXT. If investors know China will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about China SXT listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.426

Earnings Share

(3.57)

Revenue Per Share

2.223

Quarterly Revenue Growth

0.295

Return On Assets

(0.05)

The market value of China SXT Pharmaceuticals is measured differently than its book value, which is the value of China that is recorded on the company's balance sheet. Investors also form their own opinion of China SXT's value that differs from its market value or its book value, called intrinsic value, which is China SXT's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because China SXT's market value can be influenced by many factors that don't directly affect China SXT's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between China SXT's value and its price as these two are different measures arrived at by different means. Investors typically determine if China SXT is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, China SXT's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

China Historical Financial Ratios

About China Financial Ratios Analysis

China SXT Financial Ratios Chart

Price To Sales Ratio

Ptb Ratio

Book Value Per Share

Free Cash Flow Yield

Roic

China SXT fundamentals Correlations

China SXT Account Relationship Matchups

High Positive Relationship

High Negative Relationship

China SXT fundamentals Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ptb Ratio	+ 1.0	Price To Sales Ratio
Pb Ratio	+ 1.0	Price To Sales Ratio
Pb Ratio	+ 1.0	Ptb Ratio
Pocfratio	+ 1.0	Ptb Ratio
Cash Per Share	+ 1.0	Book Value Per Share
Pocfratio	+ 1.0	Pb Ratio

Pfcf Ratio	- 1.0	Pocfratio
Pfcf Ratio	- 1.0	Pb Ratio
Pfcf Ratio	- 1.0	Ptb Ratio
Pfcf Ratio	- 0.99	Price To Sales Ratio
Days Of Inventory On Hand	- 0.98	Inventory Turnover
Days Payables Outstanding	- 0.97	Payables Turnover